Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1

Journal of Leukocyte Biology

Volumn 83, Issue 2, 2008, Pages 245-253

  Björkman, Lena ^a   Karlsson, Jennie ^a   Karlsson, Anna ^a   Rabiet, Marie Josèphe ^b,c,d   Boulay, Francois ^b,c,d   Fu, Huamei ^a   Bylund, Johan ^a   Dahlgren, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CEA GRENOBLE   (France)

^c CNRS   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

FPRL1; G protein coupled receptor; Rheumatoid arthritis; WRW4

Indexed keywords

AMYLOID A PROTEIN; FORMYLPEPTIDE RECEPTOR LIKE 1; FORMYLPEPTIDE RECEPTOR LIKE 1 ANTAGONIST; LIPOPOLYSACCHARIDE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

NEGIBACTERIA;

EID: 38149083650     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0607-408     Document Type: Article

References (57)

1. Edwards, S. W. (1994) Biochemistry and Physiology of the Neutrophil, New York, NY, USA, Cambridge University Press.
2. Bokoch, G. M. (1995) Chemoattractant signaling and leukocyte activation. Blood 86, 1649-1660.
3. Fu, H., Karlsson, J., Bylund, J., Movitz, C., Karlsson, A., Dahlgren, C. (2006) Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79, 247-256.
4. Bao, L., Gerard, N. P., Eddy Jr., R. L., Shows, T. B., Gerard, C. (1992) Mapping of genes for the human C5a receptor (C5AR), human fMLP receptor (FPR), and two fMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13, 437-440.
5. Murphy, P. M., Ozcelik, T., Kenney, R. T., Tiffany, H. L., McDermott, D., Francke, U. (1992) A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267, 7637-7643.
6. Quehenberger, O., Prossnitz, E. R., Cavanagh, S. L., Cochrane, C. G., Ye, R. D. (1993) Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. J. Biol. Chem. 268, 18167-18175.
7. Boulay, F., Tardif, M., Brouchon, L., Vignais, P. (1990) Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. Commun. 168, 1103-1109.
8. Babior, B. M. (1999) NADPH oxidase: an update. Blood 93, 1464-1476.
9. Badolato, R., Wang, J. M., Murphy, W. J., Lloyd, A. R., Michiel, D. F., Bausserman, L. L., Kelvin, D. J., Oppenheim, J. J. (1994) Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180, 203-209.
10. Meek, R. L., Urieli-Shoval, S., Benditt, E. P. (1994) Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA 91, 3186-3190.
11. O'Hara, R., Murphy, E. P., Whitehead, A. S., FitzGerald, O., Bresnihan, B. (2004) Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 50, 1788-1799.
12. Urieli-Shoval, S., Cohen, P., Eisenberg, S., Matzner, Y. (1998) Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J. Histochem. Cytochem. 46, 1377-1384.
13. Artl, A., Marsche, G., Lestavel, S., Sattler, W., Malle, E. (2000) Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler. Thromb. Vasc. Biol. 20, 763-772.
14. Husebekk, A., Skogen, B., Husby, G. (1987) Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII. Scand. J. Immunol. 25, 375-381.
15. Chambers, R. E., MacFarlane, D. G., Whicher, J. T., Dieppe, P. A. (1983) Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity. Ann. Rheum. Dis. 42, 665-667.
16. Cunnane, G., Grehan, S., Geoghegan, S., McCormack, C., Shields, D., Whitehead, A. S., Bresnihan, B., Fitzgerald, O. (2000) Serum amyloid A in the assessment of early inflammatory arthritis. J. Rheumatol. 27, 58-63.
17. Urieli-Shoval, S., Linke, R. P., Matzner, Y. (2000) Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7, 64-69.
18. Jensen, L. E., Whitehead, A. S. (1998) Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334, 489-503.
19. Uhlar, C. M., Whitehead, A. S. (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265, 501-523.
20. Stone, M. J. (1990) Amyloidosis: a final common pathway for protein deposition in tissues. Blood 75, 531-545.
21. Cunnane, G. (2001) Amyloid precursors and amyloidosis in inflammatory arthritis. Curr. Opin. Rheumatol. 13, 67-73.
22. Hari-Dass, R., Shah, C., Meyer, D. J., Raynes, J. G. (2005) Serum amyloid A protein binds to outer membrane protein A of gram-negative bacteria. J. Biol. Chem. 280, 18562-18567.
23. Shah, C., Hari-Dass, R., Raynes, J. G. (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108, 1751-1757.
24. Badolato, R., Johnston, J. A., Wang, J. M., McVicar, D., Xu, L. L., Oppenheim, J. J., Kelvin, D. J. (1995) Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 155, 4004-4010.
25. Su, S. B., Gong, W., Gao, J. L., Shen, W., Murphy, P. M., Oppenheim, J. J., Wang, J. M. (1999) A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402.
26. He, R., Sang, H., Ye, R. D. (2003) Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101, 1572-1581.
27. Lee, H. Y., Kim, M. K., Park, K. S., Bae, Y. H., Yun, J., Park, J. I., Kwak, J. Y., Bae, Y. S. (2005) Serum amyloid A stimulates matrix- metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem. Biophys. Res. Commun. 330, 989-998.
28. Baranova, I. N., Vishnyakova, T. G., Bocharov, A. V., Kurlander, R., Chen, Z., Kimelman, M. L., Remaley, A. T., Csako, G., Thomas, F., Eggerman, T. L., Patterson, A. P. (2005) Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 280, 8031-8040.
29. Cai, H., Song, C., Endoh, I., Goyette, J., Jessup, W., Freedman, S. B., McNeil, H. P., Geczy, C. L. (2007) Serum amyloid A induces monocyte tissue factor. J. Immunol. 178, 1852-1860.
30. Cai, L., de Beer, M. C., de Beer, F. C., van der Westhuyzen, D. R. (2005) Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 280, 2954-2961.
31. Stonik, J. A., Remaley, A. T., Demosky, S. J., Neufeld, E. B., Bocharov, A., Brewer, H. B. (2004) Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. Biochem. Biophys. Res. Commun. 321, 936-941.
32. Cunningham, C. C., Vegners, R., Bucki, R., Funaki, M., Korde, N., Hartwig, J. H., Stossel, T. P., Janmey, P. A. (2001) Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly. J. Biol. Chem. 276, 43390-43399.
33. Boyum, A., Lovhaug, D., Tresland, L., Nordlie, E. M. (1991) Separation of leukocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand. J. Immunol. 34, 697-712.
34. Karlsson, J., Fu, H., Boulay, F., Dahlgren, C., Hellstrand, K., Movitz, C. (2005) Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors. J. Leukoc. Biol. 78, 762-771.
35. Christophe, T., Karlsson, A., Rabiet, M. J., Boulay, F., Dahlgren, C. (2002) Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. Scand. J. Immunol. 56, 470-476.
36. Dahlgren, C., Christophe, T., Boulay, F., Madianos, P. N., Rabiet, M. J., Karlsson, A. (2000) The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 95, 1810-1818.
37. Karlsson, J., Fu, H., Boulay, F., Bylund, J., Dahlgren, C. (2006) The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptde receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. Biochem. Pharmacol. 71, 1488-1496.
38. Dahlgren, C., Karlsson, A. (1999) Respiratory burst in human neutrophils. J. Immunol. Methods 232, 3-14.
39. Cross, A. R., Segal, A. W. (2004) The NADPH oxidase of professional phagocytes - prototype of the NOX electron transport chain systems. Biochim. Biophys. Acta 1657, 1-22.
40. McPhail, L. C., Clayton, C. C., Snyderman, R. (1984) The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals. J. Biol. Chem. 259, 5768-5775.
41. Bae, Y. S., Lee, H. Y., Jo, E. J., Kim, J. I., Kang, H. K., Ye, R. D., Kwak, J. Y., Ryu, S. H. (2004) Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173, 607-614.
42. Fu, H., Bylund, J., Karlsson, A., Pellme, S., Dahlgren, C. (2004) The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8. Immunology 112, 201-210.
43. Lundqvist, H., Gustafsson, M., Johansson, A., Sarndahl, E., Dahlgren, C. (1994) Neutrophil control of formylmethionyl-leucyl-phenylalanine induced mobilization of secretory vesicles and NADPH-oxidase activation: effect of an association of the ligand-receptor complex to the cytoskeleton. Biochim. Biophys. Acta 1224, 43-50.
44. Stenfeldt, A. L., Karlsson, J., Wenneras, C., Bylund, J., Fu, H., Dahlgren, C. (2007) Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation, Epub ahead of print.
45. Fu, H., Bjorkman, L., Janmey, P., Karlsson, A., Karlsson, J., Movitz, C., Dahlgren, C. (2004) The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide. BMC Cell Biol. 5, 50.
46. Monk, P. N., Scola, A. M., Madala, P., Fairlie, D. P. (2007) Function, structure and therapeutic potential of complement C5a receptors. Br. J. Pharmacol. 158, 429-448.
47. Levy, R., Rotrosen, D., Nagauker, O., Leto, T. L., Malech, H. L. (1990) Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J. Immunol. 145, 2595-2601.
48. Lee, H. Y., Jo, S. H., Lee, C., Baek, S. H., Bae, Y. S. (2006) Differential production of leukotriene B4 or prostaglandin E(2) by WKYMVm or serum amyloid A via formyl peptide receptor-like 1. Biochem. Pharmacol. 72, 860-868.
49. Christenson, K., Björkman, L., Tängemo C., Bylund J. (2007) Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. J. Leukoc. Biol., Epub ahead of print.
50. van der Westhuyzen, D. R., Cai, L., de Beer, M. C., de Beer, F. C. (2005) Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J. Biol. Chem. 280, 35890-35895.
51. Rockman, H. A., Koch, W. J., Lefkowitz, R. J. (2002) Seven-transmembrane- spanning receptors and heart function. Nature 415, 206-212.
52. Kardos, J., Nyikos, L. (2001) Universality of receptor channel responses. Trends Pharmacol. Sci. 22, 642-645.
53. Patel, H., Fellowes, R., Coade, S., Woo, P. (1998) Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 48, 410-418.
54. Mullan, R. H., Bresnihan, B., Golden-Mason, L., Markham, T., O'Hara, R., FitzGerald, O., Veale, D. J., Fearon, U. (2006) Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-κB-dependent signal transduction pathway. Arthritis Rheum. 54, 105-114.
55. Vallon, R., Freuler, F., Desta-Tsedu, N., Robeva, A., Dawson, J., Wenner, P., Engelhardt, P., Boes, L., Schnyder, J., Tschopp, C., Urfer, R., Baumann, G. (2001) Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 166, 2801-2807.
56. Jijon, H. B., Madsen, K. L., Walker, J. W., Allard, B., Jobin, C. (2005) Serum amyloid A activates NF-κB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur. J. Immunol. 35, 718-726.
57. Bylund, J., Karlsson, A., Boulay, F., Dahlgren, C. (2002) Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1. Infect. Immun. 70, 2908-2914.